Cwm, LLC Enanta Pharmaceuticals Inc Transaction History
Cwm, LLC
- $28.4 Billion
- Q2 2025
A detailed history of Cwm, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Cwm, LLC holds 21,464 shares of ENTA stock, worth $172,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,464
Previous 17,585
22.06%
Holding current value
$172,355
Previous $97,000
67.01%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ENTA
# of Institutions
113Shares Held
18.8MCall Options Held
5.6KPut Options Held
13.9K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$17 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.12MShares$17 Million6.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$16.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$14.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.35MShares$10.8 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $166M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...